Evidence map›Paper›PMID 30150477›Full record

ArticleAntimicrobial agents and chemotherapy2018

Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal Sepsis.

Glen P Carter, James E Ussher, Anders Gonçalves Da Silva, Sarah L Baines, Helen Heffernan, Thomas V Riley, Roland Broadbent, Antje van der Linden, Jean Lee, Ian R Monk and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Whole-genome sequencing ofMicrobial genomics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Multiple introductions of NRCS-AMicrobial genomics · 2025
    Article
  7. Clinical microbiology reviews · 2024
    Review
  8. Pathogens (Basel, Switzerland) · 2024
    Article
  9. Antibiotics (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Characterisation of neonatalMicrobial genomics · 2023
    Article
  12. Antibiotics (Basel, Switzerland) · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Genetic Characterization ofPathogens (Basel, Switzerland) · 2022
    Article
  17. Comparative genomics ofFrontiers in microbiology · 2022
    Article
  18. Bacteriophage-based decontamination to control environmental colonization byFrontiers in cellular and infection microbiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Glen P Carter *Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
James E Ussher *Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Anders Gonçalves Da SilvaDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Sarah L BainesDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Helen HeffernanInstitute of Environmental Science and Research, Wellington, New Zealand.
Thomas V RileyDepartment of Microbiology, PathWest Laboratory Medicine, Perth, Western Australia, Australia.
Roland BroadbentSchool of Medicine, University of Otago, Dunedin, New Zealand.
Antje van der LindenSouthern Community Laboratories, Dunedin, New Zealand.
Jean LeeDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Ian R MonkDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Timothy P StinearDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Benjamin P HowdenDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
Deborah A WilliamsonDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia deborah.williamson@unimelb.edu.au.
Peter Doherty Institute · AUThe University of Melbourne · AUUniversity of Otago · NZNew Zealand Institute for Public Health and Forensic Science · NZPathwest Laboratory Medicine · AUSouthern Community Laboratories (New Zealand) · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coagulase-negative staphylococci (CoNS), such as

Indexed as

Anti-Bacterial AgentsCoagulaseDrug Resistance, Multiple, BacterialGenomicsHumansInfant, NewbornIntensive Care Units, NeonatalNeonatal SepsisNew ZealandStaphylococcal InfectionsStaphylococcus capitisAnti-Bacterial AgentsCoagulasecoagulase-negative staphylococcigenomicsmultidrug resistanceneonatesplasmids

Identifiers

PMID30150477
PMCPMC6201123
OpenAlexW2890003113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.